Loading...
XHKG
9955
Market cap122mUSD
Jul 31, Last price  
1.49HKD
1D
-4.49%
1Q
35.45%
IPO
-94.48%
Name

ClouDr Group Ltd

Chart & Performance

D1W1MN
XHKG:9955 chart
No data to show
P/E
P/S
0.24
EPS
Div Yield, %
Shrs. gr., 5y
49.56%
Rev. gr., 5y
66.98%
Revenues
3.69b
+23.51%
284,334,082524,438,000839,123,0001,756,731,0002,988,056,0003,690,536,000
Net income
-323m
L-80.87%
-159,102,043-557,397,000-2,866,975,000-4,138,913,000-1,688,937,000-323,065,000
CFO
0k
P
-222,322,559-360,335,000-438,465,000-666,333,000-642,631,000-140,430,0000

Profile

ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
IPO date
Jul 06, 2022
Employees
1,489
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
3,690,536
23.51%
2,988,056
70.09%
Cost of revenue
4,038,156
3,579,524
Unusual Expense (Income)
NOPBT
(347,620)
(591,468)
NOPBT Margin
Operating Taxes
18
(1,422)
Tax Rate
NOPAT
(347,638)
(590,046)
Net income
(323,065)
-80.87%
(1,688,937)
-59.19%
Dividends
Dividend yield
Proceeds from repurchase of equity
(7,083)
457,069
BB yield
0.19%
-11.34%
Debt
Debt current
558,706
436,342
209,062
Long-term debt
48,909
65,377
50,450
Deferred revenue
(49,425)
Other long-term liabilities
35,756
49,425
Net debt
35,087
(128,377)
(463,663)
Cash flow
Cash from operating activities
(140,430)
(642,631)
CAPEX
(123,029)
(167,236)
Cash from investing activities
(38,341)
(744,941)
Cash from financing activities
171,814
503,548
FCF
(3,938)
(418,553)
(9,111,289)
Balance
Cash
532,156
752,961
723,175
Long term investments
40,372
(122,865)
Excess cash
572,528
445,569
573,772
Stockholders' equity
1,432,684
(9,974,614)
1,921,703
Invested Capital
1,477,151
12,209,611
1,529,432
ROIC
ROCE
EV
Common stock shares outstanding
540,820
300,298
Price
1.20
-82.48%
6.85
-48.96%
13.42
 
Market cap
3,704,617
-8.07%
4,029,999
 
EV
3,516,216
3,598,363
EBITDA
(239,441)
(479,387)
EV/EBITDA
Interest
10,782
8,021
Interest/NOPBT